Product Name

  • Name

    Thienamycin

  • EINECS 203-170-6
  • CAS No. 59995-64-1
  • Article Data13
  • CAS DataBase
  • Density 1.5g/cm3
  • Solubility
  • Melting Point
  • Formula C11H16 N2 O4 S
  • Boiling Point 514°C at 760 mmHg
  • Molecular Weight 272.325
  • Flash Point 264.7°C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 59995-64-1 (Thienamycin)
  • Hazard Symbols
  • Synonyms 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid, 3-[(2-aminoethyl)thio]-6-(1-hydroxyethyl)-7-oxo-, [5R-[5a,6a(R*)]]-;(+)-Thienamycin;Thienamycin;
  • PSA 129.16000
  • LogP 0.22420

Synthetic route

p-nitrobenzyl (5R,6S)-2-<<2-<<<(p-nitrobenzyl)oxy>carbonyl>amino>ethyl>thio>-6-<(R)-1-hydroxyethyl>carbapen-2-em-3-carboxylate
64067-13-6

p-nitrobenzyl (5R,6S)-2-<<2-<<<(p-nitrobenzyl)oxy>carbonyl>amino>ethyl>thio>-6-<(R)-1-hydroxyethyl>carbapen-2-em-3-carboxylate

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal under 2068.6 Torr;
formamidine acetic acid
3473-63-0

formamidine acetic acid

A

thienamycin
59995-64-1

thienamycin

B

(R)-5-((1R,2R)-1-Carbamoyl-2-hydroxy-propyl)-3-(2-formimidoylamino-ethylsulfanyl)-1-formyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid
130641-22-4

(R)-5-((1R,2R)-1-Carbamoyl-2-hydroxy-propyl)-3-(2-formimidoylamino-ethylsulfanyl)-1-formyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid

Conditions
ConditionsYield
at 20℃; Rate constant; Product distribution;
Conditions
ConditionsYield
With hydroxide at 20℃; Rate constant;
(3S,4R)-3-[(R)-1-hydroxyethyl]-4-[3-benzyloxycarbonyl-2-oxo-3-diazopropyl] azetidin-2-one

(3S,4R)-3-[(R)-1-hydroxyethyl]-4-[3-benzyloxycarbonyl-2-oxo-3-diazopropyl] azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multistep reaction;
2-Diazo-4-[(2R,3S)-3-((R)-1-formyloxy-ethyl)-4-oxo-azetidin-2-yl]-3-oxo-butyric acid 4-nitro-phenyl ester

2-Diazo-4-[(2R,3S)-3-((R)-1-formyloxy-ethyl)-4-oxo-azetidin-2-yl]-3-oxo-butyric acid 4-nitro-phenyl ester

ethane-1,2-dithiol
540-63-6

ethane-1,2-dithiol

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
With toluene-4-sulfonic acid In dichloromethane; isopropyl alcohol at 25℃; for 96h;
4-nitrobenzyl (2R,5R,6S)-6-[(1R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
75363-99-4

4-nitrobenzyl (2R,5R,6S)-6-[(1R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: DMAP, i-Pr2NEt / acetonitrile / 0 °C
2: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
3: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-3-[(R)-1-hydroxyethyl]-4-[3-(4-nitrobenzyl)-oxycarbonyl-2-oxopropyl]azetidin-2-one
75321-07-2

(3S,4R)-3-[(R)-1-hydroxyethyl]-4-[3-(4-nitrobenzyl)-oxycarbonyl-2-oxopropyl]azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
2: rhodium(II) acetate / benzene / 80 °C
3: DMAP, i-Pr2NEt / acetonitrile / 0 °C
4: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
5: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-3-[(R)-1-hydroxyethyl)-4-[3-(4-nitrobenzyl)oxycarbonyl-2-oxo-3-diazopropyl]azetidin-2-one
74288-39-4

(3S,4R)-3-[(R)-1-hydroxyethyl)-4-[3-(4-nitrobenzyl)oxycarbonyl-2-oxo-3-diazopropyl]azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: rhodium(II) acetate / benzene / 80 °C
2: DMAP, i-Pr2NEt / acetonitrile / 0 °C
3: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
4: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-1-(tert-Butyldimethylsilyl)-3-<(1R)-1-hydroxyethyl>-4-(carboxymethyl)azetidin-2-one
75321-05-0

(3S,4R)-1-(tert-Butyldimethylsilyl)-3-<(1R)-1-hydroxyethyl>-4-(carboxymethyl)azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: tetrahydrofuran / Ambient temperature
2: 86 percent / tetrahydrofuran / Ambient temperature
3: HCl / methanol
4: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
5: rhodium(II) acetate / benzene / 80 °C
6: DMAP, i-Pr2NEt / acetonitrile / 0 °C
7: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
8: H2 / Pd/C / 2068.6 Torr
View Scheme
(S)-1-(tert-Butyl-dimethyl-silanyl)-4-(2-trimethylsilanyl-[1,3]dithian-2-ylmethyl)-azetidin-2-one
75321-01-6

(S)-1-(tert-Butyl-dimethyl-silanyl)-4-(2-trimethylsilanyl-[1,3]dithian-2-ylmethyl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1: 82 percent Turnov. / LDA / tetrahydrofuran / -78 °C
2: K-Selectride, KI / diethyl ether / 25 °C
3: 93 percent / HgCl2, HgO / methanol; H2O / Heating
4: 76 percent / hydrogen peroxide / methanol; H2O
5: tetrahydrofuran / Ambient temperature
6: 86 percent / tetrahydrofuran / Ambient temperature
7: HCl / methanol
8: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
9: rhodium(II) acetate / benzene / 80 °C
10: DMAP, i-Pr2NEt / acetonitrile / 0 °C
11: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
12: H2 / Pd/C / 2068.6 Torr
View Scheme
Multi-step reaction with 11 steps
1: LDA / tetrahydrofuran / -78 °C
2: 93 percent / HgCl2, HgO / methanol; H2O / Heating
3: 76 percent / hydrogen peroxide / methanol; H2O
4: tetrahydrofuran / Ambient temperature
5: 86 percent / tetrahydrofuran / Ambient temperature
6: HCl / methanol
7: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
8: rhodium(II) acetate / benzene / 80 °C
9: DMAP, i-Pr2NEt / acetonitrile / 0 °C
10: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
11: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-1-(t-butyldimethylsilyl)-3-[(R)-1-hydroxyethyl]-4-(2-oxo-2-trimethylsilylethyl)-azetidin-2-one
75321-04-9

(3S,4R)-1-(t-butyldimethylsilyl)-3-[(R)-1-hydroxyethyl]-4-(2-oxo-2-trimethylsilylethyl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 76 percent / hydrogen peroxide / methanol; H2O
2: tetrahydrofuran / Ambient temperature
3: 86 percent / tetrahydrofuran / Ambient temperature
4: HCl / methanol
5: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
6: rhodium(II) acetate / benzene / 80 °C
7: DMAP, i-Pr2NEt / acetonitrile / 0 °C
8: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
9: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-1-(tert-Butyl-dimethyl-silanyl)-3-((R)-1-hydroxy-ethyl)-4-(2-imidazol-1-yl-2-oxo-ethyl)-azetidin-2-one
75333-88-9

(3S,4R)-1-(tert-Butyl-dimethyl-silanyl)-3-((R)-1-hydroxy-ethyl)-4-(2-imidazol-1-yl-2-oxo-ethyl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 86 percent / tetrahydrofuran / Ambient temperature
2: HCl / methanol
3: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
4: rhodium(II) acetate / benzene / 80 °C
5: DMAP, i-Pr2NEt / acetonitrile / 0 °C
6: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
7: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-3-Acetyl-1-(tert-butyl-dimethyl-silanyl)-4-(2-trimethylsilanyl-[1,3]dithian-2-ylmethyl)-azetidin-2-one
77551-48-5

(3S,4R)-3-Acetyl-1-(tert-butyl-dimethyl-silanyl)-4-(2-trimethylsilanyl-[1,3]dithian-2-ylmethyl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1: K-Selectride, KI / diethyl ether / 25 °C
2: 93 percent / HgCl2, HgO / methanol; H2O / Heating
3: 76 percent / hydrogen peroxide / methanol; H2O
4: tetrahydrofuran / Ambient temperature
5: 86 percent / tetrahydrofuran / Ambient temperature
6: HCl / methanol
7: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
8: rhodium(II) acetate / benzene / 80 °C
9: DMAP, i-Pr2NEt / acetonitrile / 0 °C
10: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
11: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-1-(t-butyldimethylsilyl)-3-[(R)-1-hydroxyethyl]-4-(3-p-nitrobenzyloxycarbonyl-2-oxopropyl)-azetidin-2-one
75321-06-1

(3S,4R)-1-(t-butyldimethylsilyl)-3-[(R)-1-hydroxyethyl]-4-(3-p-nitrobenzyloxycarbonyl-2-oxopropyl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: HCl / methanol
2: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
3: rhodium(II) acetate / benzene / 80 °C
4: DMAP, i-Pr2NEt / acetonitrile / 0 °C
5: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
6: H2 / Pd/C / 2068.6 Torr
View Scheme
p-nitrobenzyl (5R,6S)-2-diphenoxy phosphoryloxy-6-[(R)-1-hydroxyethyl]-1-carbapen-2-em-3-carboxylate
75321-08-3

p-nitrobenzyl (5R,6S)-2-diphenoxy phosphoryloxy-6-[(R)-1-hydroxyethyl]-1-carbapen-2-em-3-carboxylate

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
2: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-1-(tert-Butyl-dimethyl-silanyl)-3-(1-hydroxy-ethyl)-4-(2-trimethylsilanyl-[1,3]dithian-2-ylmethyl)-azetidin-2-one
75321-02-7, 75363-98-3, 75364-00-0, 80735-71-3

(3S,4R)-1-(tert-Butyl-dimethyl-silanyl)-3-(1-hydroxy-ethyl)-4-(2-trimethylsilanyl-[1,3]dithian-2-ylmethyl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1: 88 percent / TFAA, Me2SO, Et3N / CH2Cl2 / -78 °C
2: K-Selectride, KI / diethyl ether / 25 °C
3: 93 percent / HgCl2, HgO / methanol; H2O / Heating
4: 76 percent / hydrogen peroxide / methanol; H2O
5: tetrahydrofuran / Ambient temperature
6: 86 percent / tetrahydrofuran / Ambient temperature
7: HCl / methanol
8: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
9: rhodium(II) acetate / benzene / 80 °C
10: DMAP, i-Pr2NEt / acetonitrile / 0 °C
11: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
12: H2 / Pd/C / 2068.6 Torr
View Scheme
(3S,4R)-1-(tert-Butyl-dimethyl-silanyl)-3-((R)-1-hydroxy-ethyl)-4-(2-trimethylsilanyl-[1,3]dithian-2-ylmethyl)-azetidin-2-one
75321-02-7

(3S,4R)-1-(tert-Butyl-dimethyl-silanyl)-3-((R)-1-hydroxy-ethyl)-4-(2-trimethylsilanyl-[1,3]dithian-2-ylmethyl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: 93 percent / HgCl2, HgO / methanol; H2O / Heating
2: 76 percent / hydrogen peroxide / methanol; H2O
3: tetrahydrofuran / Ambient temperature
4: 86 percent / tetrahydrofuran / Ambient temperature
5: HCl / methanol
6: 90 percent / p-carboxybenzenesulfonyl azide, Et3N / acetonitrile / 0 - 20 °C
7: rhodium(II) acetate / benzene / 80 °C
8: DMAP, i-Pr2NEt / acetonitrile / 0 °C
9: 70 percent / i-Pr2NEt / acetonitrile / -5 °C
10: H2 / Pd/C / 2068.6 Torr
View Scheme
2-Diazo-4-[(2R,3S)-3-((S)-1-hydroxy-ethyl)-4-oxo-azetidin-2-yl]-3-oxo-butyric acid 4-nitro-phenyl ester

2-Diazo-4-[(2R,3S)-3-((S)-1-hydroxy-ethyl)-4-oxo-azetidin-2-yl]-3-oxo-butyric acid 4-nitro-phenyl ester

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
2: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
4-{(2R,3S)-3-[(S)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidin-2-yl}-2-diazo-3-oxo-butyric acid 4-nitro-phenyl ester

4-{(2R,3S)-3-[(S)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidin-2-yl}-2-diazo-3-oxo-butyric acid 4-nitro-phenyl ester

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: HCl / methanol; H2O
2: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
3: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(3R,4R)-4-acetoxy-3-<(S)-1-(tert-butyldimethylsilyloxy)ethyl>-2-azetidinone
78963-60-7

(3R,4R)-4-acetoxy-3-<(S)-1-(tert-butyldimethylsilyloxy)ethyl>-2-azetidinone

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 83 percent / ZnCl2 / CH2Cl2
2: HCl / methanol; H2O
3: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
4: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(2S,3S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidine-2-carbaldehyde
102046-01-5

(2S,3S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidine-2-carbaldehyde

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 86 percent / Jones reagent
2: 81 percent / acetic acid
3: 83 percent / ZnCl2 / CH2Cl2
4: HCl / methanol; H2O
5: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
6: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(2R,3S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidine-2-carbaldehyde
102129-89-5

(2R,3S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidine-2-carbaldehyde

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 96 percent / Jones reagent
2: 80 percent / acetic acid
3: 83 percent / ZnCl2 / CH2Cl2
4: HCl / methanol; H2O
5: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
6: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(2S,3S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidine-2-carboxylic acid
102129-88-4

(2S,3S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidine-2-carboxylic acid

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 81 percent / acetic acid
2: 83 percent / ZnCl2 / CH2Cl2
3: HCl / methanol; H2O
4: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
5: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(2R,3S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidine-2-carboxylic acid
102129-90-8

(2R,3S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-oxo-azetidine-2-carboxylic acid

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 80 percent / acetic acid
2: 83 percent / ZnCl2 / CH2Cl2
3: HCl / methanol; H2O
4: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
5: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
<3S,4S(E)>-3-<1(S)-hydroxyethyl>-1-(4-methoxyphenyl)-4-(2-phenylethenyl)-2-azetidinone
101977-77-9

<3S,4S(E)>-3-<1(S)-hydroxyethyl>-1-(4-methoxyphenyl)-4-(2-phenylethenyl)-2-azetidinone

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 88 percent / silylation
2: 1.) cerric ammonium nitrate / 2.) silylation
3: 91 percent / 1.) O3; 2.) Me2S / CH2Cl2 / -78 °C
4: 96 percent / Jones reagent
5: 80 percent / acetic acid
6: 83 percent / ZnCl2 / CH2Cl2
7: HCl / methanol; H2O
8: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
9: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(1'S,3S,4S)-3-(1'-<(tert-butyldimethylsilyl)oxy>ethyl)-1-(4'-methoxyphenyl)-4-(2'-phenylethenyl)-2-azetidinone
101977-83-7

(1'S,3S,4S)-3-(1'-<(tert-butyldimethylsilyl)oxy>ethyl)-1-(4'-methoxyphenyl)-4-(2'-phenylethenyl)-2-azetidinone

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 1.) cerric ammonium nitrate / 2.) silylation
2: 91 percent / 1.) O3; 2.) Me2S / CH2Cl2 / -78 °C
3: 96 percent / Jones reagent
4: 80 percent / acetic acid
5: 83 percent / ZnCl2 / CH2Cl2
6: HCl / methanol; H2O
7: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
8: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(3S,4R)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-((E)-styryl)-azetidin-2-one
102045-99-8

(3S,4R)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-((E)-styryl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 85 percent / 1.) O3; 2.) Me2S / CH2Cl2 / -78 °C
2: 86 percent / Jones reagent
3: 81 percent / acetic acid
4: 83 percent / ZnCl2 / CH2Cl2
5: HCl / methanol; H2O
6: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
7: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(3S,4S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-((E)-styryl)-azetidin-2-one
102046-00-4

(3S,4S)-1-(tert-Butyl-dimethyl-silanyl)-3-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-4-((E)-styryl)-azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 91 percent / 1.) O3; 2.) Me2S / CH2Cl2 / -78 °C
2: 96 percent / Jones reagent
3: 80 percent / acetic acid
4: 83 percent / ZnCl2 / CH2Cl2
5: HCl / methanol; H2O
6: 95 percent / Ph3P, HCOOH, EtO2CNNCO2Et / Mitsunobu's method
7: p-toluenesulfonic acid / CH2Cl2; propan-2-ol / 96 h / 25 °C
View Scheme
(3R,4R)-4-acetoxy-3-[(1R)-1-hydroxyethyl]azetidin-2-one
87037-95-4, 103365-27-1, 119720-15-9, 122673-16-9, 122673-17-0, 82938-53-2

(3R,4R)-4-acetoxy-3-[(1R)-1-hydroxyethyl]azetidin-2-one

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 81 percent / ZnI2
View Scheme
(2S,3S)-3-Acetyl-1-(tert-butyl-dimethyl-silanyl)-4-oxo-azetidine-2-carboxylic acid
82938-52-1

(2S,3S)-3-Acetyl-1-(tert-butyl-dimethyl-silanyl)-4-oxo-azetidine-2-carboxylic acid

thienamycin
59995-64-1

thienamycin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 70 percent / Diisopropylamine*borane, magnesium trifluoroacetate
2: 82 percent / dimethylformamide; acetic acid / 70 °C
3: 81 percent / ZnI2
View Scheme
thienamycin
59995-64-1

thienamycin

4-nitrobenzyl chloroformate
4457-32-3

4-nitrobenzyl chloroformate

N-<<(p-nitrobenzyl)oxy>carbonyl>thienamycin lithium salt
64066-86-0

N-<<(p-nitrobenzyl)oxy>carbonyl>thienamycin lithium salt

Conditions
ConditionsYield
With lithium hydroxide; sodium hydrogencarbonate 1.) H2O, dioxane, ice/NaCl bath; 2.) ethyl acetate, 0.05 M LiOH; Yield given. Multistep reaction;
With lithium hydroxide; sodium hydrogencarbonate 1.) H2O, dioxane, 10 min, 2.) EtOAc; Yield given. Multistep reaction;
thienamycin
59995-64-1

thienamycin

p-nitrobenzyl (5R,6S)-2-<<2-<<<(p-nitrobenzyl)oxy>carbonyl>amino>ethyl>thio>-6-<(R)-1-hydroxyethyl>carbapen-2-em-3-carboxylate
64067-13-6

p-nitrobenzyl (5R,6S)-2-<<2-<<<(p-nitrobenzyl)oxy>carbonyl>amino>ethyl>thio>-6-<(R)-1-hydroxyethyl>carbapen-2-em-3-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) NaHCO3, 2.) LiOH / 1.) H2O, dioxane, 10 min, 2.) EtOAc
2: HMPA / 2.5 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
1: 1.) NaHCO3, 2.) LiOH / 1.) H2O, dioxane, ice/NaCl bath; 2.) ethyl acetate, 0.05 M LiOH
2: 46 percent / hexamethylphosphoric acid triamide / 3 h / Ambient temperature
View Scheme
thienamycin
59995-64-1

thienamycin

p-nitrobenzyl (3S,5S,6S)-2-<<2-<<<(p-nitrobenzyl)oxy>carbonyl>amino>ethyl>thio>-6-<(R)-1-hydroxyethyl>carbapen-1-em-3-carboxylate
72778-08-6

p-nitrobenzyl (3S,5S,6S)-2-<<2-<<<(p-nitrobenzyl)oxy>carbonyl>amino>ethyl>thio>-6-<(R)-1-hydroxyethyl>carbapen-1-em-3-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) NaHCO3, 2.) LiOH / 1.) H2O, dioxane, 10 min, 2.) EtOAc
2: HMPA / 2.5 h / Ambient temperature
3: 24 percent / 1,5-diazabicyclo<5.4.0>ondec-5-ene / dimethylsulfoxide / 0.17 h / Ambient temperature
View Scheme
Multi-step reaction with 3 steps
1: 1.) NaHCO3, 2.) LiOH / 1.) H2O, dioxane, ice/NaCl bath; 2.) ethyl acetate, 0.05 M LiOH
2: 46 percent / hexamethylphosphoric acid triamide / 3 h / Ambient temperature
3: 21 percent / DBU / dimethylsulfoxide / 0.5 h
View Scheme
thienamycin
59995-64-1

thienamycin

Δ1-thienamycin
77171-32-5

Δ1-thienamycin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) NaHCO3, 2.) LiOH / 1.) H2O, dioxane, 10 min, 2.) EtOAc
2: HMPA / 2.5 h / Ambient temperature
3: 24 percent / 1,5-diazabicyclo<5.4.0>ondec-5-ene / dimethylsulfoxide / 0.17 h / Ambient temperature
4: 63 percent / H2 / 10percent Pd/c / tetrahydrofuran; ethanol / 0.5 h / Ambient temperature; phosphate buffer pH 7
View Scheme
thienamycin
59995-64-1

thienamycin

3-Hydroxy-5-[(1S,2R)-2-hydroxy-1-(morpholine-4-carbonyl)-propyl]-1H-pyrrole-2-carboxylic acid 4-nitro-benzyl ester

3-Hydroxy-5-[(1S,2R)-2-hydroxy-1-(morpholine-4-carbonyl)-propyl]-1H-pyrrole-2-carboxylic acid 4-nitro-benzyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) NaHCO3, 2.) LiOH / 1.) H2O, dioxane, 10 min, 2.) EtOAc
2: HMPA / 2.5 h / Ambient temperature
3: 2.1 mg / tetrahydrofuran / 96 h / Ambient temperature
View Scheme
thienamycin
59995-64-1

thienamycin

(2S,5S,6S)-3-[2-(4-Nitro-benzyloxycarbonylamino)-ethylsulfanyl]-6-[(R)-1-(4-nitro-benzyloxycarbonyloxy)-ethyl]-7-oxo-1-aza-bicyclo[3.2.0]hept-3-ene-2-carboxylic acid 4-nitro-benzyl ester
72843-08-4

(2S,5S,6S)-3-[2-(4-Nitro-benzyloxycarbonylamino)-ethylsulfanyl]-6-[(R)-1-(4-nitro-benzyloxycarbonyloxy)-ethyl]-7-oxo-1-aza-bicyclo[3.2.0]hept-3-ene-2-carboxylic acid 4-nitro-benzyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) NaHCO3, 2.) LiOH / 1.) H2O, dioxane, ice/NaCl bath; 2.) ethyl acetate, 0.05 M LiOH
2: 46 percent / hexamethylphosphoric acid triamide / 3 h / Ambient temperature
3: 21 percent / DBU / dimethylsulfoxide / 0.5 h
4: 49 percent / 4-(dimethylamino)pyridine / CH2Cl2 / 2.5 h / Ambient temperature
View Scheme
thienamycin
59995-64-1

thienamycin

N-<<(p-nitrobenzyl)oxy>carbonyl>-O-<<(p-nitrobenzyl)oxy>carbonyl>thienamycin p-nitrobenzyl ester
72778-09-7

N-<<(p-nitrobenzyl)oxy>carbonyl>-O-<<(p-nitrobenzyl)oxy>carbonyl>thienamycin p-nitrobenzyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) NaHCO3, 2.) LiOH / 1.) H2O, dioxane, ice/NaCl bath; 2.) ethyl acetate, 0.05 M LiOH
2: 46 percent / hexamethylphosphoric acid triamide / 3 h / Ambient temperature
3: 58 percent / 4-(dimethylamino)pyridine / CH2Cl2 / 2.5 h / Ambient temperature
View Scheme

Thienamycin Specification

The Thienamycin,with the CAS registry number 59995-64-1.It belongs to the product categories of antibiotics.This chemical's molecular formula is C11H16N2O4S and molecular weight is 272.32.

Physical properties about thienamycin are:
(1)ACD/LogP: -3.067; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -5.58; (4)ACD/LogD (pH 7.4): -5.57; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 6; (10)#H bond donors: 4; (11)#Freely Rotating Bonds: 7; (12)Index of Refraction: 1.663; (13)Molar Refractivity: 67.101 cm3; (14)Molar Volume: 181.199 cm3; (15)Surface Tension: 77.9690017700195 dyne/cm; (16)Density: 1.503 g/cm3; (17)Flash Point: 264.685 °C; (18)Enthalpy of Vaporization: 90.425 kJ/mol; (19)Boiling Point: 514.045 °C at 760 mmHg; (20)Vapour Pressure: 0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES:O=C(O)/C1=C(\SCCN)C[C@H]2N1C(=O)[C@@H]2[C@H](O)C;
(2)InChI:InChI=1S/C11H16N2O4S/c1-5(14)8-6-4-7(18-3-2-12)9(11(16)17)13(6)10(8)15/h5-6,8,14H,2-4,12H2,1H3,(H,16,17)/t5-,6-,8-/m1/s1;
(3)InChIKey:WKDDRNSBRWANNC-ATRFCDNQSA-N.

The toxicity data of Thienamycin as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD intravenous > 500mg/kg (500mg/kg)   United States Patent Document. Vol. #4006060,
mouse LD50 parenteral 1160ug/kg (1.16mg/kg)   Journal of Antibiotics. Vol. 45, Pg. 1983, 1992.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View